Brief: Lee's Pharmaceutical Says On 25 June, Unit & Panoptica Entered Binding Letter Of Intent
02/07/2020 06:41
July 2 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* ON 25 JUNE, UNIT & PANOPTICA, INC. ENTERED INTO BINDING
LETTER
OF INTENT
* LOI FOR EXCLUSIVE RIGHTS TO DEVELOP, MANUFACTURE &
COMMERCIALISE
PAN-90806 IN CHINA, HK, MACAU, SOUTH KOREA & OTHERS IN SE ASIA
* BOTH PARTIES PLAN TO COLLABORATE IN WORLD-WIDE DEVELOPMENT
OF
PAN-90806 IN WET AGE-RELATED MACULAR DEGENERATION
Source text for Eikon: ID:nHKS6Wrz0B
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA